US prepares for major reform of FDA activities this year
This article was originally published in Clinica
Executive Summary
The stage is almost set for the US Congress to consider major FDA reforms this year. Before leaving for the Christmas recess, two members of the House Energy and Commerce Committee introduced a bill aimed at giving the FDA the tools it needs to oversee the development and approval of future breakthroughs in medical technology.